Cart
sales@molnova.com
Sennoside B
CAS No. 128-57-4
Sennoside B( —— )
Catalog No. M17923 CAS No. 128-57-4
Sennoside B is an anthranoid. Anthranoid derivatives are used all over the world as a treatment for constipation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 49 | In Stock |
|
| 10MG | 60 | In Stock |
|
| 25MG | 119 | In Stock |
|
| 50MG | 182 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSennoside B
-
NoteResearch use only, not for human use.
-
Brief DescriptionSennoside B is an anthranoid. Anthranoid derivatives are used all over the world as a treatment for constipation.
-
DescriptionSennoside B is an anthranoid. Anthranoid derivatives are used all over the world as a treatment for constipation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetNMDAR
-
RecptorPDGFR
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number128-57-4
-
Formula Weight862.74
-
Molecular FormulaC42H38O20
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (115.91 mM)
-
SMILESOC[C@H]1O[C@@H](Oc2cccc3[C@H]([C@@H]4c5cccc(O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c5C(=O)c5c(O)cc(cc45)C(O)=O)c4cc(cc(O)c4C(=O)c23)C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chen YC, et al. Life Sci. 2009 Jun 19;84(25-26):915-22.
molnova catalog
related products
-
1-Aminocyclobutaneca...
1-Aminocyclobutanecarboxylic acid is a NMDA receptor partial agonist. 1-Aminocyclobutanecarboxylic acid act at the glycine site, NR1.
-
Cycloleucine
Cycloleucine is an antagonist of NMDA receptor associated glycine receptor with a Ki of 600 μM. Cycloleucine is also a competitive inhibitor of S-adenosyl-methionine mediated methylation with anxiolytic and cytostatic effects.
-
ALDH3A1-IN-1
ALDH3A1-IN-1 (Compound 18) is a potent ALDH3A1 inhibitor with an IC 50 of 1.61 μM. It is more effective than DEAB against patient-derived primary prostate tumor epithelial cells, both as a single agent and in combination with docetaxel .
